0.759
price up icon3.97%   0.029
after-market Dopo l'orario di chiusura: .73 -0.029 -3.82%
loading

Acurx Pharmaceuticals Inc Azioni (ACXP) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Operating Expenses
14.40%
4.3779
5.1146 3.115 3.4452 2.903
Income/Loss From Continuing Operations Before Tax
14.40%
-4.3779
-5.1146 -3.115 -3.4452 -2.903
Income/Loss From Continuing Operations After Tax
14.40%
-4.3779
-5.1146 -3.115 -3.4452 -2.903
Net Income/Loss
14.40%
-4.3779
-5.1146 -3.115 -3.4452 -2.903
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3,872%
15.47
0.3896 13.01 12.19 11.64
Diluted Average Shares
3,872%
15.47
0.3896 13.01 12.19 11.64
Basic Earnings Per Share
26.32%
-0.28
-0.38 -0.24 -0.28 -0.25
Diluted Earnings Per Share
26.32%
-0.28
-0.38 -0.24 -0.28 -0.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
Capitalizzazione:     |  Volume (24 ore):